- Home
- Advocacy
- Latest News and Practice Data
- CAP Lobbies Lawmakers for LDT Regulatory Relief, Higher Medicare Pay
The CAP strongly urged Congress to increase Medicare payment for pathology services and stop the Food and Drug Administration (FDA) oversight rule for laboratory-developed tests (LDTs) during a coordinated lobbying effort on November 14. In total, 26 pathologists met with 36 congressional offices, including leadership, in the House and Senate. They explained how pay cuts and burdensome LDT regulation will hurt their practices, laboratories, and communities.
The CAP is pushing Congress to enact legislation to address these two issues before lawmakers adjourn this year. All CAP members can help by visiting our Action Center and using the messaging application to contact their representatives and senators.
On LDTs, pathologists asked lawmakers to stop the FDA LDT rule by including the VALID Act, or legislation like it, in an end-of-year legislative package. At a minimum, Congress must delay implementation of the final rule to give itself time to work with stakeholders to pass legislation that includes an appropriate oversight framework with a limited role for the FDA.
CAP members also asked legislators to include an inflationary update to the Medicare physician fee schedule in the end-of-year legislative package. This would be one step in the process of providing crucial financial stability until additional, permanent bipartisan Medicare payment reforms are enacted.